Northwestern University

Running trials

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· Phase 3· Source

• Recruiting

  A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  NCT06769698· Phase 2· Source

• Recruiting

  AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

  NCT06959524· Source

• Recruiting

  A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

  NCT06991257· Phase 2· Source

• Recruiting

  Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease

  NCT06456593· Phase 2· Source

• Recruiting

  Multicenter ALS Imaging Study

  NCT06735014· Source

• Recruiting

  Health Outcomes of Parents With Cystic Fibrosis-Aim 2

  NCT06296394· Source

• Active, not recruiting

  VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

  NCT06249555· Source

• Recruiting

  Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers

  NCT06196008· Source

• Recruiting

  The Fourth Left Atrial Appendage Occlusion Study

  NCT05963698· Source

• Active, not recruiting

  Oral N-acetylcysteine for Retinitis Pigmentosa

  NCT05537220· Phase 3· Source

• Recruiting

  Left vs Left Randomized Clinical Trial

  NCT05650658· Source

• Active, not recruiting

  A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

  NCT06081894· Phase 3· Source

• Active, not recruiting

  Optimizing Outcomes for Young Autistic Children

  NCT05926687· Phase 2· Source

• Active, not recruiting

  Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

  NCT05755711· Source

• Active, not recruiting

  TrEatment Approach in the Multimodal Era Registry

  NCT05629052· Source

• Recruiting

  GEMINI-NSCLC: NSCLC Biomarker Study

  NCT05236114· Source

• Active, not recruiting

  AMP SCZ® Observational Study: PREDICT-DPACC

  NCT05905003· Source

• Recruiting

  Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

  NCT05237258· Source

• Active, not recruiting

  Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility Study

  NCT05291884· Source

• Active, not recruiting

  Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial

  NCT04835506· Phase 4· Source

• Recruiting

  Characterizing Variability in Hearing Aid Outcomes in Among Older Adults With Alzheimer's Dementia

  NCT04240561· Source

• Active, not recruiting

  Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function

  NCT04763200· Source

• Recruiting

  Parkinson's Foundation PD GENEration Genetic Registry

  NCT04994015· Source

• Recruiting

  Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

  NCT04047628· Phase 3· Source

• Active, not recruiting

  Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields

  NCT04469075· Phase 2· Source

• Recruiting

  Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  NCT03860883· Source

• Recruiting

  GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

  NCT03821129· Source

• Active, not recruiting

  Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

  NCT03824483· Phase 2· Source

• Active, not recruiting

  Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

  NCT03485209· Phase 2· Source

• Active, not recruiting

  Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

  NCT03436654· Phase 2· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease

  NCT03100149· Phase 2· Source

• Recruiting

  Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  NCT01915511· Source

• Active, not recruiting

  Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer

  NCT01688492· Phase 1/2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure2 recruiting
• Lung cancer2 recruiting
• Stroke2 recruiting
• Acute myeloid leukemia1 recruiting
• ALS (motor neurone disease)1 recruiting
• Alzheimer disease1 recruiting
• Atrial fibrillation1 recruiting
• Coronary artery disease1 recruiting
• Crohn's disease1 recruiting
• Cystic fibrosis1 recruiting
• Epilepsy1 recruiting
• Head and neck cancer1 recruiting
• Idiopathic pulmonary fibrosis1 recruiting
• Melanoma1 recruiting
• Multiple sclerosis1 recruiting
• Parkinson disease1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Recruiting

  Multicenter Study for the Validation of an AI-based ECG Platform for Early Cardiac Amyloidosis Diagnosis

  NCT06978660· Source

• Completed

  A Digital Therapeutic Platform for Swallowing and Drooling Problems in Parkinson's

  NCT04664634· Phase 3· Source

• Completed

  Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

  NCT06273124· Source

• Completed

  Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

  NCT05767346· Phase 3· Source

• Completed

  Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

  NCT05477147· Source

• Completed

  A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX

  NCT05467176· Source

• Completed

  Omnipod 5 System Compared to Pump Therapy

  NCT05409131· Source

• Completed

  Training Swallowing Initiation During Expiration

  NCT05278039· Source

• Completed

  FREEZE-AFIB Post-Market Study

  NCT05089877· Source

• Completed

  Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients

  NCT07580937· Source

• Completed

  A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness

  NCT05014672· Phase 2· Source

• Completed

  Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

  NCT05172024· Source

• Terminated

  Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects

  NCT04318145· Phase 2· Source

• Completed

  SURPASS Impella 5.5 Study

  NCT05100836· Source

• Completed

  iCLAS™ for Persistent Atrial Fibrillation

  NCT04061603· Source

• Completed

  The TESLA Trial: Thrombectomy for Emergent Salvage of Large Anterior Circulation Ischemic Stroke

  NCT03805308· Source

• Completed

  Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS

  NCT02730299· Phase 3· Source

• Completed

  Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

  NCT02089217· Source